Iodide

Iodide

SCHEMBL1932275

Cc1cc[n+](CCCC[n+]2ccc(C)cc2)cc1.[I-].[I-]

nearest known ligand 0.74

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ACHE known ✓ P22303 8/20 0.50
HTT P42858 2/20 0.74
KDM4E B2RXH2 1/20 0.54
NPC1 O15118 1/20 0.54
LMNA P02545 1/20 0.54
RAB9A P51151 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.54
BCHE P06276 8/20 0.50
MEN1 O00255 1/20 0.50
TP53 P04637 1/20 0.50
CYP1A2 P05177 1/20 0.50
CYP2D6 P10635 1/20 0.50
MAPT P10636 1/20 0.50
CYP2C9 P11712 1/20 0.50
CYP2C19 P33261 1/20 0.50
KMT2A Q03164 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12533280 0.97 HTT (0.77) HTTKDM4ENPC1LMNARAB9A
SCHEMBL12533274 0.94 HTT (0.82) HTTKDM4ENPC1LMNARAB9A
SCHEMBL4403595 0.94 HTT (0.82) HTTKDM4ENPC1LMNARAB9A
Bromide SCHEMBL30903821 0.92 HTT (0.78) HTTBCHEACHEMEN1TP53
SCHEMBL18234751 0.92 HTT (0.70) HTTKDM4ENPC1LMNARAB9A
Iodide SCHEMBL1502813 0.89 HTT (0.96) HTTKDM4ENPC1LMNARAB9A
Iodide SCHEMBL1502868 0.89 HTT (0.96) HTTKDM4ENPC1LMNARAB9A
Iodide SCHEMBL1502898 0.89 HTT (0.96) HTTKDM4ENPC1LMNARAB9A
Iodide SCHEMBL10323429 0.89 HTT (0.96) HTTKDM4ENPC1LMNARAB9A
Iodide SCHEMBL9271857 0.89 HTT (0.96) HTTKDM4ENPC1LMNARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240360318-A1 DYES FOR ANALYSIS OF PROTEIN AGGREGATION ENZO BIOCHEM, INC. (US) 2024-10-31 US disclosed
US-20210009809-A1 DYES FOR ANALYSIS OF PROTEIN AGGREGATION ENZO LIFE SCIENCES, INC. (US) 2021-01-14 US disclosed
EP-2507319-B1 DYES FOR ANALYSIS OF PROTEIN AGGREGATION ENZO LIFE SCIENCES INC (US) 2019-08-28 EP disclosed
US-20180273759-A1 DYES FOR ANALYSIS OF PROTEIN AGGREGATION ENZO LIFE SCIENCES, INC. (US) 2018-09-27 US disclosed
US-9932479-B2 Dyes and compositions, and processes for using same in analysis of protein aggregation and other applications ENZO BIOCHEM, INC. (US) 2018-04-03 US disclosed
US-20160280921-A1 DYES FOR ANALYSIS OF PROTEIN AGGREGATION ENZO LIFE SCIENCES, INC. (US) 2016-09-29 US disclosed
US-20150376411-A1 NOVEL DYES AND COMPOSITIONS, AND PROCESSES FOR USING SAME IN ANALYSIS OF PROTEIN AGGREGATION AND OTHER APPLICATIONS ENZO BIOCHEM, INC. (US) 2015-12-31 US disclosed
US-9133343-B2 Dyes and compositions, and processes for using same in analysis of protein aggregation and other applications ENZO BIOCHEM, INC. (US) 2015-09-15 US disclosed
US-20130137112-A1 DYES FOR ANALYSIS OF PROTEIN AGGREGATION ENZO LIFE SCIENCES, INC. 2013-05-30 US disclosed
EP-2507319-A2 DYES FOR ANALYSIS OF PROTEIN AGGREGATION Enzo Life Sciences, Inc. (US) 2012-10-10 EP disclosed
WO-2011065980-A2 DYES FOR ANALYSIS OF PROTEIN AGGREGATION ENZO LIFE SCIENCES, INC. (US) 2011-06-03 WO disclosed
US-20110130305-A1 Novel dyes and compositions, and processes for using same in analysis of protein aggregation and other applications ENZO LIFE SCIENCES, INC. 2011-06-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210009809-A1 DYES FOR ANALYSIS OF PROTEIN AGGREGATION CRYAA, CRYAB, HSPH1 ACHE 255/4885HTT 36/4885KDM4E 4633/4885
US-20130137112-A1 DYES FOR ANALYSIS OF PROTEIN AGGREGATION CRYAA, CRYAB, HSPH1 ACHE 255/4885HTT 36/4885KDM4E 4633/4885
US-20240360318-A1 DYES FOR ANALYSIS OF PROTEIN AGGREGATION CRYAA, CRYAB, HSPH1 ACHE 255/4885HTT 36/4885KDM4E 4633/4885
US-20110130305-A1 Novel dyes and compositions, and processes for using same in analysis of protein aggregation and other applications APP, CRYAA, CRYAB ACHE 679/4885HTT 30/4885KDM4E 4352/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.